Renal Transplantation Is Associated with Improved Clinical Outcomes in Nephrogenic Systemic Fibrosis
Table 3
Comparison between responders and non responders.
Noncategorical variables
Improved
Did not improve
Mean
SE
Mean
SE
Age in years
44.2
1.7
54.3
1
<0.001
Dialysis duration in months
32.8
7.3
56.3
5.1
<0.001
Duration to treat in weeks
31.1
6.1
10.9
3.6
<0.001
Followup duration in weeks
63.1
6.8
55.6
5.1
0.357
Categorical variables
Improved
Did not improve
%
%
Gender (25 missing data)
Male
39
50
89
45.6
0.514
Female
39
50
106
54.4
Race (204 missing data)
White
24
77.4
42
66.7
African American
3
9.7
11
17.5
0.519
Others
4
12.9
10
15.9
Prior renal transplantation (2 missing data)
Prior transplantation
29
34.9
38
17.8
0.001
No prior transplantation
54
65.1
175
82.2
T1: patients who received no treatment other than dialysis. T2: patients who received NSF specific treatment other than renal transplantation. T3: patients who received only renal transplantation. T4: patients who received NSF specific treatment followed by renal transplantation. : number of patients. SE: standard error. : probability value.
